Barr settles patent cases
-
- November
- 19
Barr Pharmaceuticals Inc., a generic drug manufacturer with major operations in Rockland County, said that it will have the rights to launch generic versions of the allergy treatments Allegra and Nasacort in settlements of patent litigation.
Sanofi-Aventis and other companies had filed the lawsuits accusing Barr with infringing patents on the medications. Sanofi-Aventis will receive royalty payments from Barr under the settlements that will end the litigation, according to Barr.
“We believe that these agreements represent a pro-consumer resolution to this ongoing litigation,” Barr Chief Executive Officer Bruce L. Downey said in a written statement.
This entry was posted
on Wednesday, November 19th, 2008 at 12:56 pm by Jay Loomis.
You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical
Print
|
Email
Leave a Reply
It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the
Terms of Service.